SGLT-2 inhibitors may simultaneously tackle kidney stones and gout flare-ups in patients with type 2 diabetes, say researchers Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada published by The BMJ today
The effect of drought stress on different isoforms of AsA-GSH cycle genes is extremely variable among different plant species
For the wider category this drip sits inside, and how it compares with other infusions on offer, see our hub on IV therapy in Vietnam
Scientific Reports 9
Endocrine 75(3):718724 Wilding JPH et al (2022) Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension
GH exerts its effects by interacting with specific receptors on a variety of target cells, including chondrocytes, osteoblasts, myocytes, hepatocytes, and adipocytes, resulting in a host of pharmacodynamic effects